methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule
- RxCUI
- 1806185
- RxNorm name
- methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule
- Display name
- methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule
- Full name
- methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylphenidate Hydrochloride (LA) | METHYLPHENIDATE HYDROCHLORIDE | Mayne Pharma | e5db854a-1c77-4faf-9e60-daf9c9b6cfa0 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | 1806185 |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Granules Pharmaceuticals Inc. | 27ea91ad-f64e-43d7-ab10-6f988bca5379 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 1806185 |
| Methylphenidate Hydrochloride (LA) | METHYLPHENIDATE HYDROCHLORIDE | Dr. Reddy's Laboratories Inc | d8c14df4-ac05-d69d-9308-58a51d568329 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 1806185 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 27ea91ad-f64e-43d7-ab10-6f988bca5379 | methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule | SY | 12 | METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | 20251008 |
| 27ea91ad-f64e-43d7-ab10-6f988bca5379 | methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule | PSN | 12 | METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | 20251008 |
| 27ea91ad-f64e-43d7-ab10-6f988bca5379 | 50/50 Release 24 HR methylphenidate hydrochloride 60 MG Extended Release Oral Capsule | SCD | 12 | METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | 20251008 |
| e5db854a-1c77-4faf-9e60-daf9c9b6cfa0 | methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule | PSN | 10 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | 20251106 |
| e5db854a-1c77-4faf-9e60-daf9c9b6cfa0 | 50/50 Release 24 HR methylphenidate hydrochloride 60 MG Extended Release Oral Capsule | SCD | 10 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | 20251106 |
| e5db854a-1c77-4faf-9e60-daf9c9b6cfa0 | methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule | SY | 10 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | 20251106 |
| d8c14df4-ac05-d69d-9308-58a51d568329 | methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | 20250930 |
| d8c14df4-ac05-d69d-9308-58a51d568329 | methylphenidate HCl 60 MG 50/50 Release 24HR Extended Release Oral Capsule | SY | 2 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | 20250930 |
| d8c14df4-ac05-d69d-9308-58a51d568329 | 50/50 Release 24 HR methylphenidate hydrochloride 60 MG Extended Release Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | 20250930 |